Page 148 - Read Online

Bale et al. Hepatoma Res 2023;9:44 https://dx.doi.org/10.20517/2394-5079.2023.71 Page 13 of 13

hepatic resection. Eur J Surg Oncol 2021;47:866-73. DOI
76. Laimer G, Jaschke N, Gottardis M, et al. Stereotactic radiofrequency ablation of an unresectable intrahepatic cholangiocarcinoma
(ICC): transforming an aggressive disease into a chronic condition. Cardiovasc Intervent Radiol 2020;43:791-6. DOI PubMed PMC
77. Braunwarth E, Schullian P, Kummann M, et al. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-stereotactic
radiofrequency ablation as a valuable addition to hepatic resection. PLoS One 2022;17:e0261136. DOI PubMed PMC
78. Bale R, Schullian P, Alzaga A. Narrative review of 3D navigated stereotactic liver ablation-do we still need a minimally invasive liver
surgeon? Laparosc Surg 2021;5. DOI
79. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of
prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140-5. DOI PubMed
80. Sposito C, Ratti F, Cucchetti A, et al. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for
clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol 2023;78:356-63. DOI PubMed
81. Koerkamp BG, Clavien PA, Polak WG. Surgical resection for intrahepatic cholangiocarcinoma - can we really improve survival by
resecting more lymph nodes? J Hepatol 2023;78:235-7. DOI PubMed
82. Mosconi C, Calandri M, Javle M, Odisio BC. Interventional radiology approaches for intra-hepatic cholangiocarcinoma. Chin Clin
Oncol 2020;9:8. DOI PubMed